Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by ventureveston Apr 26, 2010 4:04pm
432 Views
Post# 17032438

HLO way undervalued

HLO way undervalued

15. SUBSEQUENT EVENTS

(a) On December 22, 2009, the Company entered into an option and joint venture agreement with Hudson

Bay Mining and Smelting Co. Limited (“HudBay”), a subsidiary of HudBay Minerals Inc., on

certain claims (the “Cold and Lost Lakes Claims”) located in the Sherridon VMS Project area, under

which HudBay has the option to earn up to a 67.5% joint venture interest in the Cold and Lost Lake

Claims. HudBay can earn an initial 51% interest by making cash payments totalling $800,000

($250,000 received) and funding exploration programs totalling at least $1,350,000, on or before

December 22, 2011, as follows:

Date

Cash

Amounts

$

Expenditure

Commitments

$

December 22, 2009 250,000 -

December 22, 2010 150,000 350,000

December 22, 2011 400,000 1,000,000

800,000 1,350,000

Upon earning its 51% interest, HudBay can increase its interests, as follows:

i) an additional 9% interest by funding and completing a feasibility study and making a cash

payment of $2,000,000, all on or before December 22, 2012; and

ii) a further 7.5% interest by making a cash payment of $2,500,000 prior to commencement of

commercial production.

If a production decision is made, HudBay will finance the Company’s proportionate share of the

development costs and will be repaid from the Company’s proportionate share of revenues.

The option agreement also provides that the Company has the right to reacquire HudBay’s interests

earned, by partially reimbursing HudBay’s total expenditures or granting HudBay a 1% NSR if the

feasibility study and application for permitting are not complete by December 22, 2013.

<< Previous
Bullboard Posts
Next >>